Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Johan Fagman
EGFR, but Not COX‑2, Protein in Resected Pancreatic Ductal Adenocarcinoma Is Associated With Poor Survival
Oncology Letters
Cancer Research
Oncology
Related publications
Deoxycitidine Kinase Is Associated With Prolonged Survival After Adjuvant Gemcitabine for Resected Pancreatic Adenocarcinoma
Cancer
Cancer Research
Oncology
High Expression of CXCR4 May Predict Poor Survival in Resected Pancreatic Adenocarcinoma
British Journal of Cancer
Cancer Research
Oncology
Simultaneous Targeting of 5-Lox-Cox and EGFR Blocks Progression of Pancreatic Ductal Adenocarcinoma
Oncotarget
Oncology
MMP-2 but Not MMP-9 Associated With COX-2 and Survival in Gastric Cancer
Journal of Clinical Pathology
Medicine
Forensic Medicine
Pathology
Desmogleins as Prognostic Biomarkers in Resected Pancreatic Ductal Adenocarcinoma
British Journal of Cancer
Cancer Research
Oncology
A PD-L2-based Immune Marker Signature Helps to Predict Survival in Resected Pancreatic Ductal Adenocarcinoma
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Increased CDC20 Expression Is Associated With Pancreatic Ductal Adenocarcinoma Differentiation and Progression
Journal of Hematology and Oncology
Cancer Research
Oncology
Hematology
Molecular Biology
Prognostic Significance of XB130 Expression in Surgically Resected Pancreatic Ductal Adenocarcinoma
World Journal of Surgical Oncology
Surgery
Oncology
Elevated McP-1 Is Associated With Cancer Cachexia in Patients With Pancreatic Ductal Adenocarcinoma
HPB
Hepatology
Gastroenterology